BurnPhase 4NCT04781348
Efficacy of Platelet Rich Plasma Injection Plus Fat Grafting as Compared to Fat Grafting Alone on Burn Scar by Using Vancouver Scar Scale
A Phase 4 study testing Platelet Rich Plasma plus fat grafting in people with Burn, run by Dow University of Health Sciences at 1 site in Pakistan.
Trial summary
Background: - Burn injuries always leave behind some permanent marks on the body of a victim. For the treatment of these scars, digital photography along with scar scales instrument are an important instrument for the patient's evaluation and finally for the follow-up of scars. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Burn
- What is being tested?
- Platelet Rich Plasma plus fat grafting
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 64 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Mar 2021to 31 Dec 2021
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- All the buns patients of either age or sex coming with burn scar for plastic surgery.
- Give consent for this study
- Aesthetically not pleasant
- Exposed body parts
- Mature scar
Who cannot join
- Immature scar
- Systematic illness.
- Sepsis
- Psychiatric illness.
- Pregnant women
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Plastic Surgery Department, Civil Hospital Karachi (CHK)
Karachi, Sindh, 75950
About this study
Background: - Burn injuries always leave behind some permanent marks on the body of a victim. For the treatment of these scars, digital photography along with scar scales instrument are an important instrument for the patient's evaluation and finally for the follow-up of scars. Clinical evaluation of the patient after the use of Platelet concentration that it is a beneficial treatment which affects both on hard and soft tissues healing because of having growth factors deposited in PRP. Therefore, it can be used as an alternative to surgery which promotes safe and natural healing in such patients.
Objectives: -
Read more
- To determine the efficacy of Platelet Rich Plasma plus fat grafting as compared to fat grafting alone on the Vancouver scar scale.
Methodology: - An experimental controlled comparison trial study will be done on burn patients, admitted for recovery at the Plastic surgery department, Civil Hospital Karachi after the approval of the scientific committee and Institutional review board of Dow University of Health Sciences, Karachi. The study participants fulfilling the inclusion criteria giving consent will be randomly divided into two groups, one group will receive only fat grafting whereas another group will receive Platelet Rich Plasma plus fat grafting. The sample size of the study will be 52(26 in each group). Both the groups will be followed initially for 15 days of two visits then monthly two visits and finally after 6 months. Assessment of scar with Vancouver Scars Scale (VSS) will be done. The association of the PRP plus fat cells group and control group will be done by applying Chi-square statistical test. P-Value will be set for statistical significance level at <0.05.
Read the detailed description
OBJECTIVE:
- To determine the Efficacy of platelet rich plasma injection (PRP) plus fat grafting as compared to fat grafting alone on burn scar by using Vancouver Scar Scale.
HYPOTHESIS:
Null hypothesis:
There is no difference between the effect of Platelet-rich plasma (PRP) plus fat grafting and only fat grafting on the burn scar.
Alternate hypothesis:
There is a difference between the effect and adverse recovery findings of Platelet-rich plasma (PRP) plus fat grafting and only fat grafting on burn scar.
OPERATIONAL DEFINITIONS:
Platelet Rich Plasma (PRP): - Platelet-rich plasma is a blood product that has been enriched with platelets, as a concentrated source of autologous platelets. PRP contains several growth factors and other cytokines that stimulate the healing of bone and soft tissue.
Fat Grafting: - It's a purification process in which fat can be removed from different parts of the body and injected on the face and other areas of the body through a gentle harvesting technique.
Burn Scars: - Burn scars are the scars developed on any part of the body due to burning whatever cause which is depressed, raised, shiny, smooth, or rough, or darker than natural skin and maybe thicker and tougher than normal skin.
METHODOLOGY:
Setting:
Plastic Surgery Department, Civil Hospital Karachi
Study design:
This will be a randomized control trial (RCT) study.
Interventions:
Group-I: will receive only fat grafting Group-II: will receive Platelet Rich Plasma plus fat grafting
Duration:
6 months after the approval of synopsis by the authorizes
Sample size:
The sample size was calculated by Open Epi online sample size software version 3.0. Take fat grafting and PRP, 70% maintenance of contour restoring as compared to only 31% of controls with fat grafting alone 7, 80% of power and 95 confidence levels. The total calculated sample size was 52. After randomization in 8 block with size of 8. we will take 64 (34 in each group).
Block Randomization:
Principal investigator will provide treatments to the both groups. Sixty-six subjects (33 in each group) will be randomizing in 8 block with size of 8 in two treatments group by using online web page sealedenvelope/ create a randomization list. The group I will be treated with fat grafting only from recipient to donor site. Group II will be treated with Platelet-rich plasma plus fat grafting. Both the groups will be followed initially for 15 days of two visits then monthly two visits and finally after 6 months to see if there are any differences between them in outcome (burn scare).
Reference: Create a blocked randomization list | Sealed Envelope, 2021
Inclusion criteria:
- All the buns patients of either age or sex coming with burn scar for plastic surgery.
- Give consent for this study
- Aesthetically not pleasant
- Exposed body parts
- Mature scar Exclusion criteria
- Immature scar 2. Systematic illness. 3. Sepsis 4. Psychiatric illness. 5. Pregnant women
Data collection procedure:
Before starting the project, the approval of the scientific Postgraduate committee and permission from the Institutional Review Board will be taken. All the patients who fulfill the inclusion criteria will be selected for this study. Written consent of the patient will also be taken. Then the patients will be divided into two parts on a random selection basis. The group I will be treated with fat grafting only from recipient to donor site. Group II will be treated with Platelet-rich plasma plus fat grafting. The fat cells will be prepared by Coleman's technique 11. The Platelet Rich Plasma (PRP) will be prepared from (9 - 18 ml). Whole blood of the same person with centrifugation of 3000 (RPm x 3min) with anti-coagulant Citrate Phosphorus Dextrose Adenine-I (CPDA-I) and 4000 (RPm x 15 min) with Calcium Chloride for activation of platelets and normal saline to resolve-centrifugation effect.
This will be done by the highly qualifies pathologist of Dow University of Health Sciences free of cost. Both the groups will be followed initially for 15 days of two visits then monthly two visits and finally after 6 months. Assessment of scar with Vancouver Scars Scale (VSS) will be done. 16
Data analysis procedure:
The collected data will be analyzed through the Statistical Package for the Social Sciences version 20.0. The qualitative variables gender, size, and shape of scare and clinical changes will be presented in frequencies and percentages whereas quantitative variables like age, size of a scare, duration, and assessment of scar with (VSS) Vancouver scare scale will be evaluated through mean ± Standard deviation. The scar will be asses with the Vancouver Scars Scale (VSS) 16. Chi-square statistical test will be applied to assess the difference between the group. P-Value will be set for statistical significance level at <0.05. Efficacy of Platelet Rich Plasma Injection along with fat grafting as compared to fat grafting alone on burn scar in patients of plastic surgery ward of a tertiary care hospital of Karachi.
- Conditions
- Burn
- Being tested
- Platelet Rich Plasma plus fat grafting
- Keywords
- Platelet-rich plasma, Fat grafting, Efficacy, wound healing, Burns scar, Regeneration
- Medical subject headings
- Burns
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Platelet Rich Plasma plus fat graftingProcedure or surgery
The study participants fulfilling the inclusion criteria giving consent will be randomly divided into two groups, one group will receive only fat grafting whereas another group will receive Platelet Rich Plasma plus fat grafting.
| Study group | Role | What they receive |
|---|---|---|
| Platelet Rich Plasma and fat grafting | Experimental | Group will receive Platelet Rich Plasma plus fat grafting Receives: Procedure: Platelet Rich Plasma plus fat grafting |
| Fat grafting | Experimental | Group will receive only fat grafting Receives: Procedure: Platelet Rich Plasma plus fat grafting |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of change in scar
Assessment of scar with Vancouver Scars Scale
Measured: Both the groups will be followed initially for 15 days of two visits then monthly two visits and finally after 6 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Mar 2021
- Study start1 Mar 2021
- Primary completion15 Oct 2021
- Study completion31 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for BurnStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Group-I: will receive only fat grafting; Group-II: will receive Platelet Rich Plasma and fat grafting
- Masking
- None (open label)
- Enrolment
- 64 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dow University of Health Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nasreen Bano, Dow University of Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04781348
- Sponsor's protocol ID
- 1957
- Status last verified
- Feb 2023
- First submitted
- 25 Feb 2021
- Last updated
- 21 Feb 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Bendinelli P, Matteucci E, Dogliotti G, Corsi MM, Banfi G, Maroni P, Desiderio MA. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. J Cell Physiol. 2010 Nov;225(3):757-66. doi: 10.1002/jcp.22274.
PubMed 20568106Nakamura S, Ishihara M, Takikawa M, Murakami K, Kishimoto S, Nakamura S, Yanagibayashi S, Kubo S, Yamamoto N, Kiyosawa T. Platelet-rich plasma (PRP) promotes survival of fat-grafts in rats. Ann Plast Surg. 2010 Jul;65(1):101-6. doi: 10.1097/SAP.0b013e3181b0273c.
PubMed 20548232Cervelli V, Gentile P, Scioli MG, Grimaldi M, Casciani CU, Spagnoli LG, Orlandi A. Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods. 2009 Dec;15(4):625-34. doi: 10.1089/ten.TEC.2008.0518.
PubMed 19231923Cervelli V, Gentile P, De Angelis B, Calabrese C, Di Stefani A, Scioli MG, Curcio BC, Felici M, Orlandi A. Application of enhanced stromal vascular fraction and fat grafting mixed with PRP in post-traumatic lower extremity ulcers. Stem Cell Res. 2011 Mar;6(2):103-11. doi: 10.1016/j.scr.2010.11.003. Epub 2010 Nov 30.
PubMed 21195687Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001 Jan;107(1):229-37; discussion 238-9. doi: 10.1097/00006534-200101000-00037.
PubMed 11176628Chandarana S, Fung K, Franklin JH, Kotylak T, Matic DB, Yoo J. Effect of autologous platelet adhesives on dermal fat graft resorption following reconstruction of a superficial parotidectomy defect: a double-blinded prospective trial. Head Neck. 2009 Apr;31(4):521-30. doi: 10.1002/hed.20999.
PubMed 19156832Brusselaers N, Pirayesh A, Hoeksema H, Verbelen J, Blot S, Monstrey S. Burn scar assessment: a systematic review of different scar scales. J Surg Res. 2010 Nov;164(1):e115-23. doi: 10.1016/j.jss.2010.05.056. Epub 2010 Jun 16.
PubMed 20828761Jin R, Zhang L, Zhang YG. Does platelet-rich plasma enhance the survival of grafted fat? An update review. Int J Clin Exp Med. 2013 Apr 12;6(4):252-8. Print 2013.
PubMed 23641301
Study at a glance
From the registry record, last updated by the sponsor on 21 Feb 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of Platelet Rich Plasma Injection Plus Fat Grafting as Compared to Fat Grafting Alone on Burn Scar by Using Vancouver Scar Scale
- ClinicalTrials.gov ID
- NCT04781348
- Acronym / sponsor ID
- 1957
- Conditions
- Burn
- Keywords
- Platelet-rich plasma, Fat grafting, Efficacy, wound healing, Burns scar, Regeneration
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 64 participants (actual)
- Lead sponsor
- Dow University of Health SciencesUniversity, hospital or other
- Study start
- 1 Mar 2021 (actual)
- Primary completion
- 15 Oct 2021 (actual)
- Study completion
- 31 Dec 2021 (actual)
- First posted
- 4 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: - Burn injuries always leave behind some permanent marks on the body of a victim. For the treatment of these scars, digital photography along with scar scales instrument are an important instrument for the patient's evaluation and finally for the follow-up of scars. Clinical evaluation of the patient after the use of Platelet concentration that it is a beneficial treatment which affects both on hard and soft tissues healing because of having growth factors deposited in PRP. Therefore, it can be used as an alternative to surgery which promotes safe and natural healing in such patients.
Objectives: -
- To determine the efficacy of Platelet Rich Plasma plus fat grafting as compared to fat grafting alone on the Vancouver scar scale.
Methodology: - An experimental controlled comparison trial study will be done on burn patients, admitted for recovery at the Plastic surgery department, Civil Hospital Karachi after the approval of the scientific committee and Institutional review board of Dow University of Health Sciences, Karachi. The study participants fulfilling the inclusion criteria giving consent will be randomly divided into two groups, one group will receive only fat grafting whereas another group will receive Platelet Rich Plasma plus fat grafting. The sample size of the study will be 52(26 in each group). Both the groups will be followed initially for 15 days of two visits then monthly two visits and finally after 6 months. Assessment of scar with Vancouver Scars Scale (VSS) will be done. The association of the PRP plus fat cells group and control group will be done by applying Chi-square statistical test. P-Value will be set for statistical significance level at <0.05.
Detailed description
OBJECTIVE:
- To determine the Efficacy of platelet rich plasma injection (PRP) plus fat grafting as compared to fat grafting alone on burn scar by using Vancouver Scar Scale.
HYPOTHESIS:
Null hypothesis:
There is no difference between the effect of Platelet-rich plasma (PRP) plus fat grafting and only fat grafting on the burn scar.
Alternate hypothesis:
There is a difference between the effect and adverse recovery findings of Platelet-rich plasma (PRP) plus fat grafting and only fat grafting on burn scar.
OPERATIONAL DEFINITIONS:
Platelet Rich Plasma (PRP): - Platelet-rich plasma is a blood product that has been enriched with platelets, as a concentrated source of autologous platelets. PRP contains several growth factors and other cytokines that stimulate the healing of bone and soft tissue.
Fat Grafting: - It's a purification process in which fat can be removed from different parts of the body and injected on the face and other areas of the body through a gentle harvesting technique.
Burn Scars: - Burn scars are the scars developed on any part of the body due to burning whatever cause which is depressed, raised, shiny, smooth, or rough, or darker than natural skin and maybe thicker and tougher than normal skin.
METHODOLOGY:
Setting:
Plastic Surgery Department, Civil Hospital Karachi
Study design:
This will be a randomized control trial (RCT) study.
Interventions:
Group-I: will receive only fat grafting Group-II: will receive Platelet Rich Plasma plus fat grafting
Duration:
6 months after the approval of synopsis by the authorizes
Sample size:
The sample size was calculated by Open Epi online sample size software version 3.0. Take fat grafting and PRP, 70% maintenance of contour restoring as compared to only 31% of controls with fat grafting alone 7, 80% of power and 95 confidence levels. The total calculated sample size was 52. After randomization in 8 block with size of 8. we will take 64 (34 in each group).
Block Randomization:
Principal investigator will provide treatments to the both groups. Sixty-six subjects (33 in each group) will be randomizing in 8 block with size of 8 in two treatments group by using online web page sealedenvelope/ create a randomization list. The group I will be treated with fat grafting only from recipient to donor site. Group II will be treated with Platelet-rich plasma plus fat grafting. Both the groups will be followed initially for 15 days of two visits then monthly two visits and finally after 6 months to see if there are any differences between them in outcome (burn scare).
Reference: Create a blocked randomization list | Sealed Envelope, 2021
Inclusion criteria:
- All the buns patients of either age or sex coming with burn scar for plastic surgery.
- Give consent for this study
- Aesthetically not pleasant
- Exposed body parts
- Mature scar Exclusion criteria
- Immature scar 2. Systematic illness. 3. Sepsis 4. Psychiatric illness. 5. Pregnant women
Data collection procedure:
Before starting the project, the approval of the scientific Postgraduate committee and permission from the Institutional Review Board will be taken. All the patients who fulfill the inclusion criteria will be selected for this study. Written consent of the patient will also be taken. Then the patients will be divided into two parts on a random selection basis. The group I will be treated with fat grafting only from recipient to donor site. Group II will be treated with Platelet-rich plasma plus fat grafting. The fat cells will be prepared by Coleman's technique 11. The Platelet Rich Plasma (PRP) will be prepared from (9 - 18 ml). Whole blood of the same person with centrifugation of 3000 (RPm x 3min) with anti-coagulant Citrate Phosphorus Dextrose Adenine-I (CPDA-I) and 4000 (RPm x 15 min) with Calcium Chloride for activation of platelets and normal saline to resolve-centrifugation effect.
This will be done by the highly qualifies pathologist of Dow University of Health Sciences free of cost. Both the groups will be followed initially for 15 days of two visits then monthly two visits and finally after 6 months. Assessment of scar with Vancouver Scars Scale (VSS) will be done. 16
Data analysis procedure:
The collected data will be analyzed through the Statistical Package for the Social Sciences version 20.0. The qualitative variables gender, size, and shape of scare and clinical changes will be presented in frequencies and percentages whereas quantitative variables like age, size of a scare, duration, and assessment of scar with (VSS) Vancouver scare scale will be evaluated through mean ± Standard deviation. The scar will be asses with the Vancouver Scars Scale (VSS) 16. Chi-square statistical test will be applied to assess the difference between the group. P-Value will be set for statistical significance level at <0.05. Efficacy of Platelet Rich Plasma Injection along with fat grafting as compared to fat grafting alone on burn scar in patients of plastic surgery ward of a tertiary care hospital of Karachi.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Group-I: will receive only fat grafting; Group-II: will receive Platelet Rich Plasma and fat grafting
| Arm | Type | Receives |
|---|---|---|
| Platelet Rich Plasma and fat grafting | Experimental | Procedure: Platelet Rich Plasma plus fat graftingGroup will receive Platelet Rich Plasma plus fat grafting |
| Fat grafting | Experimental | Procedure: Platelet Rich Plasma plus fat graftingGroup will receive only fat grafting |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- All the buns patients of either age or sex coming with burn scar for plastic surgery.
- Give consent for this study
- Aesthetically not pleasant
- Exposed body parts
- Mature scar
Key exclusion criteria (5 listed)
- Immature scar
- Systematic illness.
- Sepsis
- Psychiatric illness.
- Pregnant women
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Platelet Rich Plasma plus fat graftingThe study participants fulfilling the inclusion criteria giving consent will be randomly divided into two groups, one group will receive only fat grafting whereas another group will receive Platelet Rich Plasma plus fat grafting. | Procedure or surgery | Fat grafting, Platelet Rich Plasma and fat grafting |
Primary outcome
Assessment of change in scar
Time frame: Both the groups will be followed initially for 15 days of two visits then monthly two visits and finally after 6 months.
Assessment of scar with Vancouver Scars Scale
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Feb 2023.
- Background: PubMed 20568106Bendinelli P, Matteucci E, Dogliotti G, Corsi MM, Banfi G, Maroni P, Desiderio MA. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. J Cell Physiol. 2010 Nov;225(3):757-66. doi: 10.1002/jcp.22274.
- Background: PubMed 20548232Nakamura S, Ishihara M, Takikawa M, Murakami K, Kishimoto S, Nakamura S, Yanagibayashi S, Kubo S, Yamamoto N, Kiyosawa T. Platelet-rich plasma (PRP) promotes survival of fat-grafts in rats. Ann Plast Surg. 2010 Jul;65(1):101-6. doi: 10.1097/SAP.0b013e3181b0273c.
- Background: PubMed 19231923Cervelli V, Gentile P, Scioli MG, Grimaldi M, Casciani CU, Spagnoli LG, Orlandi A. Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods. 2009 Dec;15(4):625-34. doi: 10.1089/ten.TEC.2008.0518.
- Background: PubMed 21195687Cervelli V, Gentile P, De Angelis B, Calabrese C, Di Stefani A, Scioli MG, Curcio BC, Felici M, Orlandi A. Application of enhanced stromal vascular fraction and fat grafting mixed with PRP in post-traumatic lower extremity ulcers. Stem Cell Res. 2011 Mar;6(2):103-11. doi: 10.1016/j.scr.2010.11.003. Epub 2010 Nov 30.
- Background: PubMed 11176628Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001 Jan;107(1):229-37; discussion 238-9. doi: 10.1097/00006534-200101000-00037.
- Background: PubMed 19156832Chandarana S, Fung K, Franklin JH, Kotylak T, Matic DB, Yoo J. Effect of autologous platelet adhesives on dermal fat graft resorption following reconstruction of a superficial parotidectomy defect: a double-blinded prospective trial. Head Neck. 2009 Apr;31(4):521-30. doi: 10.1002/hed.20999.
- Results publication: PubMed 20828761Brusselaers N, Pirayesh A, Hoeksema H, Verbelen J, Blot S, Monstrey S. Burn scar assessment: a systematic review of different scar scales. J Surg Res. 2010 Nov;164(1):e115-23. doi: 10.1016/j.jss.2010.05.056. Epub 2010 Jun 16.
- Results publication: PubMed 23641301Jin R, Zhang L, Zhang YG. Does platelet-rich plasma enhance the survival of grafted fat? An update review. Int J Clin Exp Med. 2013 Apr 12;6(4):252-8. Print 2013.
- Individual participant dataSharing planned: No
Related trials for Burn
RecruitingObservational study
Early Detection and Kinetics of Sepsis-Induced Coagulopathy in Severe Burn Patients
Sepsis, Sepsis-induced Coagulopathy
Not yet recruitingObservational study
Hypertrophic Scar Prosthetic Pressure in Burn Amputee
Amputation Stump, Burn Injury
Not yet recruiting
Effect of Short-Video Distraction During Burn Dressing on Anxiety, Pain, and Fear in Children
Burn Injury, Procedural Anxiety
RecruitingObservational study
Early Detection and Kinetics of Sepsis-Induced Coagulopathy in Severe Burn Patients
Peer Bullying Intervention, Vodcast
RecruitingPhase 2
Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic
Pruritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Platelet Rich Plasma plus fat grafting in people with Burn, run by Dow University of Health Sciences at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of change in scar (time frame: Both the groups will be followed initially for 15 days of two visits then monthly two visits and finally after 6 months.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04781348, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2023.